INTRODUCTION
Neurofilaments (NFs) are the most abundant cytoskeletal components in large myelinated axons and exist as obligated heteropolymers composed of NF-L, NF-M and NF-H (1-3). Each NF is composed of three domains: a N-terminal head domain, an α-helix-rich rod domain, and a C-terminal tail domain (4) (5) (6) . The head domain regulates filament assembly via protein phosphorylation (7) (8) (9) . The rod domain is responsible for coiled-coil dimer formation, which is an essential step in neurofilament assembly (10) . In vitro reconstitution studies revealed that NF-L assembles to form core filaments (11) , while NF-L alone cannot assemble into the filaments in vivo (12) (13) (14) . Within a cell, NF-L unconditionally requires NF-M or NF-H to form neurofilaments via cross-bridging of NF-L/NF-M and/or NF-L/NF-H (2, 15) . Fully formed heteropolymeric neurofilaments composed of NF-L/NF-M and/or NF-L/NF-H are key components of axonal neurites.
Mutations in the human NF-L (hNF-L) gene have recently been shown to cause Charcot-Marie-Tooth disease (CMT), which is characterized by demyelination and axonal degeneration of neurons. Among the mutant forms of hNF-L linked to CMT are several encoded by missense mutations, including P8L, P8Q, P8R, P22S, P22T, E89K, N97S, A148V, Q333P, L334P and D469N (16) (17) (18) (19) (20) (21) (22) . With the exception of hNF-L-A148V, which has not been tested in cultured cell systems, each of these mutant proteins causes aggregation of hNF-L, consistent with the proposed relationship between CMT and point mutations in the hNF-L gene. To examine the capability for filament formation by the A148V mutant in vitro and in vivo, we cloned a human cDNA for wild type NF-L and mutated it to A148V and A296T as a control. Here we demonstrate for the first time that exogenously expressed hNF-L-A148V is unable to form filamentous structures in SW13 cells, suggesting that the A148V mutation is also associated with CMT.
RESULTS AND DISCUSSION

Preparation of cDNA for human NF-L
An analysis of cDNA from CMT patients reveals the existence of point mutations in the NF-L gene (Fig. 1A ) that cause disassembly of NF-L (16) (17) (18) (19) (20) (21) (22) . The effect of these mutations on filament assembly has been confirmed by phenotypic analysis of mutant NF-L proteins exogenously expressed in SW13 cells. However, the most recently discovered A148V mutant, which has not been previously characterized, exhibits exception. To facilitate such a phenotypic analysis of the A148V mutation in SW13 cells, we amplified a DNA fragment that matched the expected size of the hNF-L coding region using a human rain cDNA library (Fig. 1B) . Comparison of the resulting DNA sequence to public database NCBI showed that this product was indeed hNF-L, which has a reading frame of 1,632 bp encoding 543 amino acids (Fig. 1C) . We have also prepared the corresponding hNF-L-A148V mutant construct and verified that the substitution of alanine for valine at position 148 was correctly introduced (Fig. 1C) . In our recent study, since substitution of alanine for threonine at position 296 in rod-domain http://bmbreports.org BMB reports Amplification of the hNF-L gene from a human fetal brain marathon cDNA library using human NF-L-specific primers yields a PCR product of the predicted size. hNF-L-A148V and -A296T mutations were prepared by substituting alanine for valine at position 148, and alanine for threonine at position 296 using PCR-directed mutagenesis respectively. (C) Sequences of NF-L wild type and NF-L mutants (A148V and A296T) were confirmed as described in Materials and Methods.
of NF-L did not affect self assembly (data not shown), we used this A296T mutation of NF-L as a negative mutant control for all subsequent experiments.
Phenotypic expression of human NF-L in SW13 cells
Generally, NF-L self-assembles to form a "core" filament that provides a scaffold for NF-M or NF-H, leading to the formation of neurofilaments in most neurons. In vitro studies have shown that NF-L self-assembles in the presence of Ca 2+ but it dose not polymerize to a filamentous form in vivo (23) . This indicates that in vivo filament formation of NF-L requires at least NF-M or NF-H (24). The vimentin-deficient human adrenal carcinoma SW13 cell (25) is a model cell that is permissive for intermediate filament formation upon co-expression of NF-L with NF-M or NF-H (1, 2). As previous reports, SW13 cells transfected with NF-M and NF-L-full (full length)-WT together showed intermediate filament formation but not in cells transfected with NF-L-full-WT alone ( Fig. 2A) . Based on these results, subsequent experiments for NF-L filament formation were performed in the presence of co-transfected NF-M. We next analyzed the phenotypic expression of the NF-L-full length with a rod domain A148V mutation in SW13 cells. Co-expression of GFP-NF-L-full-WT with Flag-NF-M formed filamentous structures (Fig. 2B ). A296T mutation in the rod domain of NF-L, a negative mutation control, also formed typical intermediate filament in SW13 cells. However, the rod domain mutation A148V mutation drastically abolished filament formation despite presence of NF-M, indicating an indispensable function for alanine at position 148 in the formation of structural filaments within neuronal cells. Moreover, this phenotype is similar to that reported for other CMT-linked mutations (18) (19) (20) 22) . This result also indicates that the A148V mutation may also be closely associated with CMT. Green fluorescence indicating NF-L-full-WT and NF-L-full-mutants (A148V and A296T) completely merged to red color reflecting NF-M subcellular distribution in SW13 cells. Western analysis http://bmbreports.org of SW13 cell lysates transfected with the indicated genes confirmed the expression of wild type and mutant NF-Ls as GFP fusion proteins (Fig. 2C, bottom) and the exogenous overexpression of NF-M (Fig. 2C, top) .
A148V mutant in rod domain of NF-L abolishes self assembly
We previously reported that head-rod domains of NF-L were sufficient for detecting the levels of self-assembled NF-L and that GST-fused head-rod domains (H/R) of NF-L are critical tools for analyzing NF-L self-assembly in vitro (26) . Based on this finding, we assessed whether A148V mutation influenced self-assembly of NF-L in vitro. To clarify this, GST-NF-L-H/R, GST-NF-L-H/R-A148V and GST-NF-L-H/R-A296T fusion proteins were mixed with E.coli-purified full length NF-L (NF-Lfull-WT), and incubated for 1 h at 4 o C. Associated proteins were recovered by centrifugation, washed extensively, and analyzed by Western immunoblotting. As shown in (Fig. 3B, lanes 1 and 2) . The http://bmbreports.org BMB reports graph represents densitometirc western blotting (lower) and schematic diagrams (left) present designated experiments.
How does the A148V mutant of human NF-L lead to defective filament assembly and the formation of aggregates? Although our experiments do not address this question, in case of P22T and P22S head-domain mutations related to CMT, their mutations have been reported to result in shorter and thinner intertwined filaments versus normally polymerized filaments in an in vitro assembly assay (27) . Based on the ability of head domain of NF-L to polymerize core filaments (2), the mutation of alanine to valine at position 148 may cause failure of dimerization known to be mediated by coiled coil region in NF-L rod domain (10) . Interactions of hydrophobic amino acids have known to form coiled coil dimers in the α-helical rod domain (28) . Since alanine and valine are similar, both nonpolar aliphatic residues, and their substitution has no known effect on protein structure (28), A148V mutation may be considered a polymorphism and uninfluential towards production traits. Our findings, that A148V mutation abolished NF-L self assembly as well as in vivo filament formation, may also be linked with other unknown mechanism. This hypothesis is likely supported by findings of A117V substitution in prion protein and its link to Gerstmann-Sträussler-Scheinker disease (GSS) of humans, possibly through favoring β-sheet conformation over the α-helical conformation (29) . Kirschner et al also showed that substitutions of alanine at position 117 with various hydrophobic amino acids did not destabilize the helix conformation, only valine substitution resulted in helix destabilization leading to failure of hydrophobic interactions (30) .
Since ionic strength (10, 23) and treatment of Ca 2+ (26) affects NF-L self assembly, we next investigated the effect of Ca 2+ on self-assembly by NF-L-WT or NF-L-A148V mutant. 
Purified E.coli-NF-L-full-WT and E.coli-NF-L-full-A148V
both E.coli-NF-L-full-WT plus NF-L-H/R and E.coli-NF-L-full
-A148V plus NF-L-H/R-A148V in a dose dependent manner, confirming that Ca 2+ treatment induces not only the levels of self-assembly of intact NF-L, but also restoring A148V mutation-reduced NF-L self-assembly. It is likely that A148V mutation on the central rod domain of NF-L may fail to dimerize but this can be recovered by Ca 2+ through mediation of certain conformational changes on the rod domain.
Overexpression of NF-L-A148V mutant in PC12 cells co-expressing NF-M and NF-H
We next investigated the effect of exogenously introduced NF-L-full-A148V mutant on filament formation in PC12 cells that co-express NF-M and NF-H in contrast to SW13 cells which lack these proteins (25) . PC12 cells were transfected with GFP-NF-L-full-WT, GFP-NF-L-full-A148V or GFP-NF-L-full-A296T. Filament formations were visualized by fluorescent confocal microscopy. Overexpression of GFP-NF-L-full-WT and GFP-NF-L-full-A296T formed typical intermediate filaments with a fine and continuous network, whereas NF-L-full-A148V mutant overexpression, at least in part, caused smaller and thinner cytoplasmic aggregates than NF-L-WT-cells, although long filamentous networks were observed in most of the transfected cells (Fig. 4) . This result suggests that the NF-L-A148V mutant has a dominant negative effect, and it partially blocks self-assembly of endogenous NF-L assembly leading to intermediate filament formation with NF-M and NF-H in PC12 cells.
Taken together, the mutation of alanine to valine at position 148 in human NF-L rod domain abolished assembly into intermediate filaments in vivo and reduced self-assembly of NF-L in vitro. These results suggest that NF-L-A148V mutation is one of the mutations causing CMT.
MATERIALS AND METHODS
Reagents
Monoclonal (mAb 1615) and polyclonal anti-NF-L antibodies were purchased from Chemicon (Temecula, CA). Monoclonal anti-NF-M antibody (mAb RNF403) used in immunocytochemistry applications was from MP Biochemicals (Aurora, OH). Horseradish peroxidase (HRP)-conjugated goat anti-mouse and goat anti-rabbit antibodies were from Upstate Inc. (Lake Placid, NY). Fluorescein-conjugated Affinipure goat anti-rabbit IgG and rhodamine-conjugated Affinipure goat anti-mouse IgG were from Jackson ImmunoResearch Laboratories (West Grove, PA). PCR reagents were from Roche Diagnostics (Mannheim, Germany) and the human fetal brain marathon cDNA library (Cat # S0623) was purchased from CLONTECH (Palo Alto, CA).
PCR cloning
The hNF-L gene was amplified from a human fetal brain marathon cDNA library (Clontech) by PCR using the following primers: 5'-GCT GAA TTC ATG AGT TCC TTC AGC TAC GAG-3' (forward), and 5'-CAT GTC GAC TCA ATC TTT CTT CTT AGC TGC-3' (reverse). Italicized sequences correspond to EcoRI and SalI restriction sites added to the 5' ends of forward and reverse primers, respectively, to facilitate cloning. The resulting PCR product (1.6 kb) was directionally cloned into EcoRI and SalI sites of the pGEX5x-1 vector (Amersham Pharmacia) to generate a plasmid, designated pGEX5x-1-hNF-L, containing the full-length, wild-type hNF-L gene. The identity of the gene was confirmed by DNA sequencing.
Site-directed mutagenesis
The mutations of alanine at position 148 to valine and alanine at position 296 to threonine in hNF-L were performed by PCR-directed mutagenesis using pGEX5x-1-hNF-L as a template. Mutagenic primers for A148V are as follows: 5'-CTG CGC CTG GTG GCG GAA GAT-3' (forward) and 5'-ATC TTC CGC CAC CAG GCG CAG-3' (reverse); or mutagenic primers used for A296T: 5'-AAC ACC GAC ACC GTG CGC GCC-3' (forward) and 5'-GGC GCG CAC GGT GTC GGT GTT-3' (reverse). DNA sequencing using the dideoxy chain termination method confirmed that the desired substitutions were introduced at the appropriate codon to yield pGEX5x-1-hNF-L-A148V or -A296T.
Additional expression constructs
The EGFP-containing hNF-L expression plasmids were prepared by ligating pGEX5x-1-hNF-L or pGEX5x-1-hNF-L-A148V into EcoRI and SalI sites of pEGFP. Rat NF-M cDNA (rNF-M; kindly provided by Dr. Liem R. K. H., Columbia University) was ligated into the XbaI site of pREFA generating the expression plasmid, pREFA-rNF-M. All constructs were prepared using the Qiagen Plasmid Maxi Kit (Qiagen Inc., Santa Clarita, CA), and confirmed through direct sequencing of ligation junctions.
Cell culture
The vimentin-deficient (Vim -) human adrenal carcinoma SW13 cell line was cultured in Dulbecco's Modified Eagles Media (DMEM) supplemented with 10% fetal bovine serum (FBS).
Analysis of intermediate filament formation
To study intermediate filament formation in mammalian cells, http://bmbreports.org BMB reports rNF-M combined with either EGFP-hNF-L or EGFP-hNF-L-A148V fusion proteins were exogenously expressed in SW13 cells and examined using immunofluorescence microscopy. For transfections, SW13 cells were seeded onto glass coverslips in six-well plates, then co-transfected with pREFA-rNF-M and either pEGFP-hNF-L or pEGFP-hNF-L-A148V using a calcium phosphate co-precipitation kit (Promega, Madison, WI). Following transfection, cells were grown for 2 days in DMEM, then fixed at 37 o C for 10 min in 4% paraformaldehyde and incubated with monoclonal anti-NF-M for 1 h at room temperature in a humidified chamber. The cells were washed with phosphate buffered saline (PBS), and then incubated with rhodamine-conjugated Affinipure goat anti-mouse IgG. Immunostained cells were observed using laser confocal microscopy.
Neurofilament-L protein purification
After E.coli (BL21) was transfected with a full-length cDNA clone of human NF-L in a pET-3d vector, bacteria was grown in a Luria broth containing 1 mM isopropyl β-Dthiogalactopyranoside at 37 for 3 h. Bacteria was harvested and resuspended in a standard buffer (50 mM MES, 170 mM NaCl, 1 mM DTT, pH 6.25). The cells were lysed with a French press at a pressure of 20,000 psi and centrifuged at 8,000 × g for 15 min at 4 o C. The supernatant was incubated for 3 h at 37 o C, then centrifuged at 100,000 × g for 20 min at 25 o C. The aggregated NF-L proteins were washed twice with a standard buffer and dissolved in a urea buffer (25 mM Na-phosphate, pH 7.5, 6 M urea, 1 mM EGTA, and 1 mM DTT). The sample loaded onto a DEAE-Sepharose column was also washed with the urea buffer. The column was eluted with a linear 25-500 mM phosphate gradient in the urea buffer and the NF-L was eluted between 300 and 360 mM phosphate (31) . The protein concentration was determined by the BCA method (32) .
In vitro assay of NF-L self-assembly
Purified GST-NF-L-head (H), -rod (R), -tail (T), -head-rod (H/R) and head-rod-tail (F) domain fusion proteins were mixed with E.coli-purified native NF-L in Igepal buffer containing 1% bovine serum albumin, and incubated for 1 h at 4 o C. The associated proteins were recovered by centrifugation, washed extensively, and analyzed by Western immunoblotting. Purified NF-L (2.5 μg) and the bead-bound GST-NF-L (H/R) fusion proteins (0.5 μg each) were incubated for 1 hr at 35 o C. After extensive washing, the proteins bound to the beads were resolved by 10% SDS-PAGE and immunoblotted with anti-NF-L. The GST-NF-L-(H/R) bands with an anti-GST antibody represent the loading control.
